VSIG10L: A Potential Drug Target for Immune System Modulation

Target Name: VSIG10L

NCBI ID: G147645

Other Name(s): V-set and immunoglobulin domain containing 10 like | V-set and immunoglobulin domain-containing protein 10-like | VS10L_HUMAN | VSIG10-like protein

VSIG10L: A Potential Drug Target for Immune System Modulation

VSIG10L, also known as V-set and immunoglobulin domain-containing 10 like, is a protein that plays a crucial role in the immune system. It is a member of the V-set gene family, which includes proteins that are involved in the development and maintenance of immune tolerance. VSIG10L is a 10-kDa protein that is expressed in a variety of tissues, including blood cells, lymph nodes, and Peyer's patches.

VSIG10L functions as a receptor for antigens, allowing the immune system to recognize and respond to them. It is part of the MHC class I molecules, which are responsible for presenting antigens to T-cells. VSIG10L is involved in the recognition of both self and foreign antigens, and its function in this process is critical for maintaining immune tolerance.

VSIG10L is also involved in regulating the activation and proliferation of immune cells. It plays a role in the development of natural killer cells, which are a critical part of the immune system that are responsible for killing infected or mutated cells. VSIG10L is also involved in the regulation of inflammation, helping to prevent excessive or chronic inflammation.

VSIG10L is a potential drug target for several reasons. Firstly, VSIG10L is a well-established protein that has been studied extensively, making it a promising candidate for drug development. Secondly, VSIG10L is involved in several key processes in the immune system, making it an attractive target for drugs that are designed to modulate the immune response. Finally, VSIG10L is a protein that is expressed in a variety of tissues, making it a potential biomarker for tracking the effectiveness of drugs.

VSIG10L's Structure and Functions

VSIG10L is a 10-kDa protein that is expressed in a variety of tissues, including blood cells, lymph nodes, and Peyer's patches. It is a member of the V-set gene family, which includes proteins that are involved in the development and maintenance of immune tolerance. VSIG10L is characterized by a calculated molecular weight of 115.1 kDa and a predicted localization of 11.9% in the endoplasmic reticulum.

VSIG10L is involved in several key processes in the immune system. It is a receptor for antigens, allowing the immune system to recognize and respond to them. It is part of the MHC class I molecules, which are responsible for presenting antigens to T-cells. VSIG10L is involved in the recognition of both self and foreign antigens, and its function in this process is critical for maintaining immune tolerance.

VSIG10L is also involved in regulating the activation and proliferation of immune cells. It plays a role in the development of natural killer cells, which are a critical part of the immune system that are responsible for killing infected or mutated cells. VSIG10L is also involved in the regulation of inflammation, helping to prevent excessive or chronic inflammation.

VSIG10L is a potential drug target due to its involvement in several key processes in the immune system. It is a well-established protein that has been studied extensively, making it a promising candidate for drug development. VSIG10L is also involved in several potential drug targets that could be targeted by small molecules, antibodies, or other therapeutic approaches.

VSIG10L as a Potential Drug Target

VSIG10L is a potential drug target due to its involvement in several key processes in the immune system. Its involvement in the immune response makes it an attractive target for drugs that are designed to modulate the immune response. VSIG10L is a protein that is expressed in a variety of tissues, making it a potential biomarker for tracking the effectiveness of drugs.

VSIG10L can be targeted by small molecules, antibodies, or other therapeutic approaches. For example, VSIG10L

Protein Name: V-set And Immunoglobulin Domain Containing 10 Like

More Common Targets